Blog

Blogs Blogs Blogs Blogs Blogs Blogs Blogs Blogs Blogs Blogs

Offering sponsors end-to-end strategic drug development and technology-enabled regulatory services to reduce time, cost, and risk, from discovery through post-registration.
image

PRICING AND MARKET ACCESS STRATEGY FOR A SCD PRODUCT IN GCC

ur client has a sickle disease portfolio and wanted to understand how to optimally launch in GCC markets through understanding price potential and feasibility of innovative contracting in order to boost patient access

  • In depth secondary research was conducted focusing on understanding the prevalence ofSCD, patient journey and competitor products
  • Conducted primary research consisting of qualitative and quantitative discussions to understand the nuances within the SCD landscape across key geographies alongside to testing the price and access potential for a SCD drug
  • In depth secondary research was conducted focusing on understanding the prevalence ofSCD, patient journey and competitor products
Blogs Regulatory Affairs and Drug Development Solutions (RADDS)